Quantcast

Partnering for Philanthropy Conference Launched to Unite Innovative Non-Profit Research Organizations With Philanthropists and Industry

June 17, 2008

WASHINGTON, NEW YORK, and SAN DIEGO, June 17 /PRNewswire/ — DMS Data Systems, Demy-Colton Life Science Advisors, the EBD Group and FasterCures today announced plans to launch Partnering for Philanthropy, a new partnering meeting designed to promote funding of non-profit medical research and patient advocacy groups, and to facilitate partnering between those groups and biopharmaceutical companies. The inaugural meeting will be held in New York City in June 2009.

According to FasterCures, non-profit foundations are ideally positioned to make relatively high-risk, high-reward investments that could significantly move a field of research forward. However, the lack of independent, reliable data about non-profit disease research opportunities is a major barrier to encouraging significant support for such research and to improving the efficiency and productivity of the philanthropy.

The new Partnering for Philanthropy meeting is designed to leverage and expand the critical role philanthropic funders can play in stimulating research in under-resourced disease areas, and help bridge the widening “valley of death” in research funding between basic discovery and later-stage research.

“We believe there is a strong need to bridge the information gap separating philanthropy and non-profit medical research organizations if we are to accelerate medical solutions,” said Greg Simon, President, FasterCures. “This meeting will help narrow this gap by infusing the medical research philanthropic process with the right information, the appropriate tools, and the networks to connect diverse groups.”

“A well-recognized translational research gap also exists in the drug development path between the end of academic research funding and the beginning of typical biopharmaceutical drug development programs,” stated Rick Franklin, Chairman of DMS Data Systems. “The new Partnering for Philanthropy conference will bridge this gap and provide an opportunity for non-profit medical research and patient advocacy organizations to pinpoint vital funding and development commitments from pharmaceutical and biotech companies alongside philanthropists engaged in funding medical innovation.”

Partnering for Philanthropy will offer researchers and potential developers and/or funding sources access to a proprietary online partnering system that will provide profiles of organizations, provide information resources and allow users to arrange meetings in real-time. Panel discussions at the conference will also focus directly on new developments in venture philanthropy and translational research. Preliminary program components will include:

   --  Presentations by leading medical research and patient advocacy groups   --  Plenary sessions and panel discussions on translational research       funding   --  Case studies of investment by non-profit organizations in       biotechnology companies   --  One-on-one meetings between medical research and patient advocacy       organizations, philanthropists and biopharmaceutical companies   --  Networking opportunities    

“This event is modeled after the partnering meetings developed by the Biotechnology Industry Organization (BIO) and EBD Group which have changed the way pharmaceutical and biotechnology companies exchange information and do business,” said Sara Jane Demy of Demy-Colton Life Science Advisors. “We believe the Partnering for Philanthropy conference will create extraordinary and much-needed opportunities to accelerate new drug development across numerous therapeutic fields.”

About DMS Data Systems: DMS Data Systems provides business information to the medical industry in the form of online databases. Its products include the NewsAnalyzer, a database of all press releases issued by all medical and pharmaceutical companies; the IndustryAnalyzer, a database of 6000 medical and pharmaceutical company profiles; and Clinical Trials Plus, a database containing all registered clinical trials.

About Demy-Colton Life Science Advisors: Demy-Colton is a consulting company focused exclusively on facilitating the growth of the life sciences industry. Sara Demy, the principal of Demy-Colton and previously the Biotechnology Industry Organization’s Vice President of Business Development and Investor Relations, is a leader at designing and developing high-value added programs and services to address the business needs of the biotechnology industry. She has deep domain knowledge and over twenty-years experience, which she will apply to launching new industry programs, and counseling local and regional organizations that wish to increase the level of services they provide their biotechnology constituents.

About EBD Group: EBD Group is the leading firm for partnering in the life sciences. EBD Group organizes its own landmark conferences for the biotechnology and pharmaceutical industries. Building on this expertise, and with an unrivaled access to major players in these markets, EBD provides partnering services to other event organizers, and hands-on business development consultancy to support strategic partnering worldwide.

About FasterCures: FasterCures/The Center for Accelerating Medical Solutions is committed to saving lives by saving time in the research, discovery and development of new treatments for deadly and debilitating diseases. FasterCures, as a center of the Milken Institute, is non-partisan, non-profit and independent of interest groups. With grants from the Bill and Melinda Gates Foundation and the Robert Wood Johnson Foundation, FasterCures is developing the Philanthropy Advisory Service, providing detailed information about patient advocacy groups and other non-profit medical organizations.

Partnering for Philanthropy

CONTACT: Jon Franklin of DMS Data Systems, +1-202-248-6900,jon.franklin@dmsdatasystems.com; or Sara Demy of Demy-Colton Life ScienceAdvisors, +1-212-332-4381, sdemy@demy-colton.com




comments powered by Disqus